Ma et al. [21] revealed that the knockdown or overexpression of SPRY4-IT1 can lead to changes in protein levels within the TNF signaling pathway, suggesting that the long non-coding RNA SPRY4-IT1-mediated TNF signaling pathway could be a therapeutic target for hepatocellular carcinoma. The gene discussed is SPRY4; the disease is hepatocellular carcinoma.